Social Factors and Survival After a Childhood Central Nervous System Tumor in Sweden, Denmark, and Finland: A Register‐Based Cohort Study
ABSTRACT Studies suggest that survival after a childhood central nervous system (CNS) tumor varies across social factors, but findings are inconsistent and largely based on older cohorts. We aimed to determine whether social factors were associated with childhood CNS tumor survival and explored how this association has evolved over time in three Nordic countries. This register‐based cohort study included children aged 0–19 years diagnosed with a CNS tumor during 1993–2022 in Sweden, Denmark, and Finland (aged 0–15 years, 1993–2016 in Finland). Parental educational level was examined in all three countries. Additional individual‐level (parental country of birth, employment status, cohabitation, and household disposable income) and area‐based (education, income) social factors were studied in Sweden and Denmark. Using Cox regression models, we estimated adjusted hazard ratios (aHR) and 95% confidence intervals (CI) to evaluate the association between social factors and 10‐year all‐cause mortality. Among 4703 children diagnosed with CNS tumors, social factors were not uniformly associated with mortality across the study period. Among children diagnosed 1993–2007, lower maternal and area‐based educational levels were associated with higher mortality (comparing least vs. most educated groups: aHR, 95% CI maternal education: 1.30, 1.03–1.65; area‐based education: 1.36, 0.99–1.88). Among children diagnosed 2008–2022, children with one Nordic and one non‐Nordic parent had higher mortality than children with only Nordic parents (aHR: 1.54; 95% CI: 1.09–2.19). In conclusion, while education‐related disparities seem to have diminished in recent years, emerging differences by parental country of birth warrant continued monitoring.
Authors
- Ole Raaschou‐Nielsen (ORCID: https://orcid.org/0000-0002-1223-0909)
- Elena Extrand (ORCID: https://orcid.org/0009-0000-0816-1480)
- Friederike Erdmann (ORCID: https://orcid.org/0000-0002-9982-3300)
- Jad Abuhamed (ORCID: https://orcid.org/0000-0002-4798-7004)
- Giorgio Tettamanti (ORCID: https://orcid.org/0000-0002-5210-7219)
- Hanna Mogensen (ORCID: https://orcid.org/0000-0001-5195-8065)
- Kleopatra Georgantzi (ORCID: https://orcid.org/0000-0001-9304-6144)
- Christina‐Evmorfia Kampitsi (ORCID: https://orcid.org/0000-0002-3907-4360)
- Javier Louro (ORCID: https://orcid.org/0000-0002-2985-3301)
- Maike Wellbrock (ORCID: https://orcid.org/0000-0002-5885-7002)
- Hannah L. Brooke (ORCID: https://orcid.org/0000-0002-7085-1551)
- Ulla Arthur Hvidtfeldt (ORCID: https://orcid.org/0000-0002-0335-4838)
- Anssi Auvinen
- Maria Feychting
Institutions
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Tampere University (FI)
- Aarhus University (DK)
- Karolinska Institutet (SE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Tampere University Hospital (FI)
- Danish Cancer Society (DK)
- University of Tampere (FI)
Publication Details
- Journal
- International Journal of Cancer
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1002/ijc.70811
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00